XYTIS
Xytis is a biopharmaceutical company focusing on the discovery and development of innovative CNS drug candidates. The company is privately held and was created in Jan 2006 by the merger of Xytis Pharmaceuticals Ltd. (UK) and Remergent, Inc. (USA). The company received funding from Sanderling Ventures, Atlas Venture, CDC Entreprises Innovation, and Ventech. Xytis Inc. is assembling a pipeline of innovative compounds with validated mechanisms of action, addressing major unmet clinical needs in CNS fields such as Schizophrenia, Traumatic Brain Injury, Depression, Anxiety, or Insomnia. The company has two clinical stage compounds in development and operates from the USA, UK and Switzerland.
XYTIS
Industry:
Biotechnology Health Care Medical Device
Founded:
2006-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.xytis.com
Total Employee:
1+
Status:
Closed
Contact:
949-725-3700
Total Funding:
24.5 M USD
Technology used in webpage:
SPF Amazon PHP Amazon Virginia Region Amazon Ohio Region NameBright Oversee.net Hosted
Investors List
Atlas Venture
Atlas Venture investment in Series B - Xytis
Sanderling Ventures
Sanderling Ventures investment in Series B - Xytis
Ventech
Ventech investment in Series B - Xytis
CDC Enterprises
CDC Enterprises investment in Series B - Xytis
Official Site Inspections
http://www.xytis.com
- Host name: ec2-54-243-117-197.compute-1.amazonaws.com
- IP address: 54.243.117.197
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
